Nationwide Fund Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Nationwide Fund Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,242	Closed	-$15K	–	3260
2017 Q1	$15K	Hold	1,242	–	–	﹤0.01%	3106
2016 Q4	$27K	Hold	1,242	–	–	﹤0.01%	3065
2016 Q3	$95K	Hold	1,242	–	–	﹤0.01%	2907
2016 Q2	$94K	Buy	1,242 +109	+10%	+$8.77K	﹤0.01%	2938
2016 Q1	$99K	Hold	1,133	–	–	﹤0.01%	2822
2015 Q4	$134K	Hold	1,133	–	–	﹤0.01%	2734
2015 Q3	$100K	Hold	1,133	–	–	﹤0.01%	2896
2015 Q2	$123K	Buy	1,133 +496	+78%	+$61.7K	﹤0.01%	2948
2015 Q1	$80K	Buy	637 +2	+0.3%	+$260	﹤0.01%	3015
2014 Q4	$81K	Hold	635	–	–	﹤0.01%	2955
2014 Q3	$85K	Sell	635 -31	-5%	-$4.34K	﹤0.01%	3030
2014 Q2	$108K	Sell	666 -43	-6%	-$7.32K	﹤0.01%	3002
2014 Q1	$157K	Buy	709 +9	+1%	+$2.29K	﹤0.01%	2587
2013 Q4	$180K	Buy	+700	New	+$160K	﹤0.01%	2737

Other funds holding TNDM

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nationwide Fund Advisors's TNDM Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2017, closing a stake of 1,242 shares — an estimated $15K sold.

Nationwide Fund Advisors first reported a position in TNDM in Q4 2013 and held it in 14 quarters. The position peaked at $180K in Q4 2013. 63 funds tracked by Wall St. Rank hold TNDM as of Q2 2017.

Nationwide Fund Advisors reported no remaining Tandem Diabetes Care position as of Q2 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 1,242 Tandem Diabetes Care shares in Q2 2017, an estimated $15K.
Nationwide Fund Advisors first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 14 quarters.
Nationwide Fund Advisors's Tandem Diabetes Care position peaked at $180K in Q4 2013.
63 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.